 CENTOGENE CNTG, a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced the expansion of its Senior Leadership Team with the appointment of Angelos Baxevanis as Senior Vice President Communication and Marketing. With nearly two decades of experience in the field, Angelos will have the overall responsibility of further developing the marketing and communication strategies, establishing internal marketing workflows, and further positioning CENTOGENE as a leading provider of medical solutions for rare disease patients. Angelos joins CENTOGENE from AAB Consulting Inc. where he was working with Sobi Pharmaceuticals in various projects on enhancing commercial capabilities in the rare disease area. 